Regulatory Education for Industry (REdI) Annual Conference 2024: Drugs Track
The drugs track will address major advances and innovation across various aspects of the drug development spectrum. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development - 05/29/2024
Regulatory Education for Industry (REdI) Annual Conference 2024: Innovation in Medical Product Development (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 8, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Quality Metrics for Drug Manufacturing
Quality Metrics Data Reporting: This program will help FDA to address common quality issues in the pharmaceutical industry, address product shortage issues, and encourage modernization of pharmaceutical manufacturing. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Roundup: April 5, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ivermectin and COVID-19
There continues to be interest in a drug called ivermectin for the prevention or treatment of COVID-19 in humans. The FDA has not authorized or approved ivermectin for use in preventing or treating COVID-19 in humans or animals. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Aruba Aloe Balm N.V. Issues Voluntary Nationwide Recall of Aruba Aloe Hand Sanitizer Gel Alcohol 80% and Aruba Aloe Alcoholada Gel Due to Presence of Methanol
Oranjestad, Aruba, Aruba Aloe Balm N.V. is voluntarily recalling 40 lots of Aruba Aloe Hand Sanitizer Gel Alcohol 80% and Aruba Aloe Alcoholada Gel to the consumer level. The products have been found to contain alcohol denatured with methanol. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Honeywell Safety Products USA, Inc. Issues Voluntary Worldwide Recall of Honeywell Fendall 2000 Non-Sterile Eyewash Cartridges # 32-002050-0000 used with the Fendall 2000 Eyewash Station Due to a Lack of Appropriate Policies and Procedures by Honeywell ’s Supplier
Charlotte, NC, Honeywell Safety Products USA, Inc. is voluntarily recalling Fendall 2000 Non-Sterile Eyewash Cartridge for the Fendall 2000 Eyewash Station. This recall is being conducted at the industrial consumer level. Honeywell ’s supplier of the Fendall 2000 Non-Sterile Eyewash Cartridge has bee (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 5, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves New Antibiotic for Three Different Uses
The FDA approved a new antibiotic for the treatment of certain patients with Staphylococcus aureus bloodstream infections, including those with right-sided infective endocarditis; acute bacterial skin and skin structure infections; and community-acquired bacterial pneumonia. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Ceftobiprole Medocaril Sodium for Injection
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Golden Lab LLC - 625783 - 03/22/2024
Unapproved New Drugs/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 3, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Roundup: April 2, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Drug Trials Snapshots: NGENLA
NGENLA is a human growth hormone for the treatment of children 3 years of age and older who are not growing because they have growth hormone deficiency (GHD). (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How to Safely Dispose of Unused or Expired Medicine (60 seconds) - Video Transcript
(Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Desh ágase de manera segura de los medicamentos opioides antes de que puedan hacer daño - Transcripción
Desh ágase de manera segura de los medicamentos opioides antes de que puedan hacer daño - Transcripción (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news

How to Safely Dispose of Unused or Expired Medicine - Video Transcript
How to Safely Dispose of Unused or Expired Medicine (FULL) - Video Transcript (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - April 2, 2024 Category: Drugs & Pharmacology Authors: FDA Source Type: news